Literature DB >> 7520164

Differential immunohistochemical staining for retinoblastoma protein with the antibodies C15 and 1F8 in malignant mesothelioma.

M Ramael1, K Segers, E Van Marck.   

Abstract

The results of an immunohistochemical study of retinoblastoma protein in human non-neoplastic mesothelium (40 cases) and in malignant mesothelioma (36 cases) using the antibodies 1F8 and C15 are reported. All cases of malignant mesothelioma and non-neoplastic mesothelium were immunoreactive in more than 75% of the mesothelial cells for retinoblastoma protein with the C15 polyclonal antibody. Immunoreactivity for retinoblastoma protein was virtually absent with the 1F8 monoclonal body in neoplastic cells of all investigated mesotheliomas. In contrast, stromal cells in these mesotheliomas and all cases with non-neoplastic mesothelium were immunoreactive with the monoclonal antibody 1F8 in more than 75% of the cells. These findings may be indicative for the presence of an abnormal retinoblastoma protein in malignant mesothelioma lacking an epitope coded for between exons 21-27.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520164     DOI: 10.1016/S0344-0338(11)80703-X

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

Review 1.  Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

Authors:  J W Upham; M J Garlepp; A W Musk; B W Robinson
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

Review 2.  Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.

Authors:  J F Lechner; J Tesfaigzi; B I Gerwin
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

3.  High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines.

Authors:  S Ungar; A Van de Meeren; L Tammilehto; K Linnainmaa; K Mattson; B I Gerwin
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.